Literature DB >> 24976806

Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.

Olga C Aroniadis1, Lawrence J Brandt1.   

Abstract

Fecal microbiota transplantation (FMT) refers to the infusion of a fecal suspension from a healthy person into the gastrointestinal (GI) tract of another person to cure a specific disease. FMT is by no means a new therapeutic modality, although it was only relatively recently that stool was shown to be a biologically active, complex mixture of living organisms with great therapeutic potential for recurrent Clostridium difficile infection and perhaps other GI and non-GI disorders. The published revelations about the human microbiome are bringing the strength of science to clinical observation and enhancing the understanding of not only disease but also how much of a person's daily function and health depends on the microorganisms living in intimate relationship with each cell in the body.

Entities:  

Keywords:  Clostridium difficile; Fecal microbiota transplantation; inflammatory bowel disease; irritable bowel syndrome

Year:  2014        PMID: 24976806      PMCID: PMC4073534     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  69 in total

Review 1.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

Review 2.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

Review 3.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

4.  Putting back the bugs: bacterial treatment relieves chronic diarrhoea.

Authors:  D L Paterson; J Iredell; M Whitby
Journal:  Med J Aust       Date:  1994-02-21       Impact factor: 7.738

5.  Postinfectious irritable bowel syndrome--a meta-analysis.

Authors:  Heather A Halvorson; Carey D Schlett; Mark S Riddle
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

6.  Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.

Authors:  Sonia S Yoon; Lawrence J Brandt
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

7.  Treatment of ulcerative colitis using fecal bacteriotherapy.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn Leis; Rosa Surace; Ori Ashman
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

8.  Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7.

Authors:  Yoshika Momose; Kazuhiro Hirayama; Kikuji Itoh
Journal:  Antonie Van Leeuwenhoek       Date:  2008-02-05       Impact factor: 2.271

9.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

10.  Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

Authors:  Elaine O Petrof; Gregory B Gloor; Stephen J Vanner; Scott J Weese; David Carter; Michelle C Daigneault; Eric M Brown; Kathleen Schroeter; Emma Allen-Vercoe
Journal:  Microbiome       Date:  2013-01-09       Impact factor: 14.650

View more
  19 in total

Review 1.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 2.  Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Authors:  Anastasia I Petra; Smaro Panagiotidou; Erifili Hatziagelaki; Julia M Stewart; Pio Conti; Theoharis C Theoharides
Journal:  Clin Ther       Date:  2015-05-01       Impact factor: 3.393

Review 3.  Microbiome and its impact on gastrointestinal atopy.

Authors:  A B Muir; A J Benitez; K Dods; J M Spergel; S A Fillon
Journal:  Allergy       Date:  2016-06-23       Impact factor: 13.146

Review 4.  Environmental triggers in IBD: a review of progress and evidence.

Authors:  Ashwin N Ananthakrishnan; Charles N Bernstein; Dimitrios Iliopoulos; Andrew Macpherson; Markus F Neurath; Raja A Raja Ali; Stephan R Vavricka; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

5.  Assessment of the Urinary Microbiota of MSM Using Urine Culturomics Reveals a Diverse Microbial Environment.

Authors:  Sanjam S Sawhney; Caitlin Johnson; Angela Shupe; Jeremy Fine; Gautam Dantas; Carey-Ann D Burnham; Melanie L Yarbrough
Journal:  Clin Chem       Date:  2021-12-30       Impact factor: 8.327

Review 6.  Systemic effects of gut microbiota and its relationship with disease and modulation.

Authors:  Jolie T K Ho; Godfrey C F Chan; James C B Li
Journal:  BMC Immunol       Date:  2015-03-26       Impact factor: 3.615

Review 7.  Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Brian E Lacy
Journal:  Int J Gen Med       Date:  2016-02-11

Review 8.  Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation.

Authors:  Franco Aversa; Lucia Prezioso; Ilenia Manfra; Federica Galaverna; Angelica Spolzino; Alessandro Monti
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-25       Impact factor: 2.576

9.  Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.

Authors:  Emilie Baro; Tatiana Galperine; Fanette Denies; Damien Lannoy; Xavier Lenne; Pascal Odou; Benoit Guery; Benoit Dervaux
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

Review 10.  Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut.

Authors:  Audrey Rivière; Marija Selak; David Lantin; Frédéric Leroy; Luc De Vuyst
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.